Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

The Center for Immuno-Oncology (CIO) investigates how our immune system reacts to cancer and what we can do to improve tumour immunity.  We combine deep fundmental understanding of immunology with preclinical studies to translate new knowledge into clinical trials with the aim of developing new life-saving treatments for a spectrum of cancers. 

Oxford’s long history of excellence in immunology is now focused on cancer, and CIO is the hub of the University-wide Oxford Cancer Immuno-Oncology Network (OCION) which links immuno-oncology researchers from multiple disciplines from across the University of Oxford, its affiliated hospitals and industrial partners.


World Cancer Day

Discover how our researchers are tackling the major challenges in Cancer Research 🔬🧬 👉Featuring here Dr.Pedroza-Pacheco, Dr. Galvez-Cancino and and Dr.Leung from our Centre for immuno-Oncology 🎥 Watch the video to see the breakthroughs we're striving for! #Innovation

United by unique

This year’s #WorldCancerDay theme is 'United by Unique' and our work at the Centre for immuno-Oncology aligns with it by using fundamental science and exploring environmental factors to develop innovative personalised therapies

The future of Cancer Resarch

At the centre for immuno-Oncology we are focusing on improving patient outcomes through personalized approaches Watch the video to see how we’re transforming the future for cancer patients. 🎥 #CancerWorldDay

Immunotherapies in CIO

Social media

CIO News

Alice's Arc co-founder, Sara Wakeling, with her daughter Alice, who died five years after her rhabdomyosarcoma diagnosis.

CIO and Dunn School Join Forces to Pioneer Vaccines Against Childhood Cancers

A new partnership between Alice’s Arc, the Centre for Immuno-Oncology in the Nuffield Department of Medicine and the Sir William Dunn School of Pathology will pioneer the development of a bespoke mRNA vaccine to improve treatment outcomes for children with rhabdomyosarcoma, a rare and aggressive form of soft tissue cancer.

A Day of Science, Creativity, and Connection at the CIO Away Day

The Centre for Immuno-Oncology came together last week for a vibrant and inspiring CIO Away Day. In the beautiful Rhodes house we enjoyed a full day of science, creativity, reflection, and community.

Professor Andrew McMichael elected to the US National Academy of Sciences

The National Academy of Sciences (NAS) in the US announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and is considered one of the highest honours that a scientist can receive.

Dr. Pedroza-Pacheco presenting at the Oxford Immunology Symposium last year (2024)

Oxford Immunology Symposium 2025

The BSI Oxford Immunology Group, in collaboration with the University of Oxford Immunology Network, is pleased to present a one-day showcase of the fantastic immunology research happening across Oxford.

Oxford Cancer News

Latest publications

Oxford Talks